Terapi sel T CAR Dokter Terbaik di Israel - TOP-11 dokter

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel punca (stem cell) dan menerbitkan lebih dari 30 artikel ilmiah di bidang hematologi dan onkologi.

• Bersertifikat dewan (Board-certified) dalam Ilmu Penyakit Dalam, Hematologi, dan Onkologi Medis
• Menempuh pelatihan Fellowship di New York Medical College
• Berspesialisasi dalam keganasan hematologi dan transplantasi
• Kontributor akademis, termasuk sebagai penulis bab buku ajar

Dr. Ram Ron berspesialisasi dalam terapi sel T CAR di Pusat Medis Sourasky (Ichilov), membawa keahlian yang luas untuk pengobatan canggih ini.

• Berfokus pada terapi seluler mutakhir
• Bekerja di pusat medis terkemuka untuk onkologi
• Didedikasikan untuk pendekatan pengobatan yang dipersonalisasi

Kepala Onkohematologi Anak di Rumah Sakit Anak Dana Dwek – Dr. Ronit El Hasid berspesialisasi dalam transplantasi sumsum tulang dan darah untuk anak-anak.

• Telah melakukan 300+ prosedur transplantasi
• Telah menerbitkan 50+ makalah medis
• Telah mempresentasikan penelitian di 40+ konferensi
• Fellow dari American Association for Hematology (Asosiasi Hematologi Amerika)
• Pelatihan di City of Hope Hospital di Los Angeles

Dr. Michael Shapira berspesialisasi dalam Transplantasi Sumsum Tulang di Pusat Medis Sourasky (Ichilov), dengan pengalaman yang luas di bidang tersebut.

• Lulus dari Fakultas Kedokteran Universitas Ibrani pada tahun 1999
• Berspesialisasi dalam penyakit dalam di Pusat Medis Hadassah
• Dokter senior di bidang Transplantasi Sumsum Tulang di Hadassah
• Fasih berbahasa Inggris dan Ibrani

Direktur hematologi onkologi pediatrik di Pusat Medis Sourasky – berspesialisasi dalam terapi sel T CAR untuk anak-anak dengan kelainan darah dan sarkoma.

• Dokter anak senior di Rumah Sakit Anak Dana
• Pelatihan di Institut Ortopedi Rizzoli – salah satu pusat terkemuka dunia untuk kanker tulang
• Anggota ISPHO – asosiasi hemato-onkologi pediatrik Israel
• Mengkoordinasikan program perawatan sarkoma untuk anak-anak

Dengan 31 tahun pengalaman, Dr. Aviv berspesialisasi dalam terapi sel T CAR di Pusat Medis Sourasky (Klinik Ichilov).

• Berfokus secara eksklusif pada onkohematologi
• Pengalaman luas dengan terapi seluler canggih
• Praktik di salah satu pusat medis terkemuka di Israel

Dr. Yair telah memberikan kontribusi signifikan terhadap hematologi, khususnya dalam leukemia limfositik kronis, dengan sejumlah penghargaan dan penelitian yang telah diterbitkan.

• Penerima berbagai penghargaan bergengsi, termasuk Klitzberg Oncology Award
• Anggota Asosiasi Hematologi Israel dan Amerika
• Pelatihan ekstensif dalam hematologi di Pusat Medis Tel Aviv
• Aktif dalam penelitian dengan hibah dari Yayasan Sains Israel (Israeli Science Foundation)

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.